Abstract | BACKGROUND: METHODS: A sample of 152 IMRT-treated, biopsy-proven, nondisseminated NPC patients were retrospectively analysed. All had documented IMRT treatment plans and had returned for follow-up review at 4 years post- radiotherapy. Spasm of the sternocleidomastoid (SCM) muscle was graded from 0 to 3 (absent to severe) and this grade served as the clinical endpoint. Risk factors were identified using logistic regression analysis. RESULTS: Within 4 years of radiotherapy, neck muscle spasm developed in 23.68% of the patients; Grades 0, 1, 2 and 3 were respectively assigned to 83.55, 7.57, 6.58 and 2.30% of assessed SCMs. Multivariate analysis indicated that gender, N stage, V60 (percentage of SCM volume that received >60 Gy) were independent prognostic variables, and that the optimal threshold for using V60 to predict neck muscle spasm was 61.92% (sensitivity = 0.900, specificity = 0.953). CONCLUSIONS: Gender, N stage and V60 were independent predictive factors for post- radiotherapy neck muscle spasm, and a V60 of ≤61.92% in the SCM was relatively safe.
|
Authors | Lu-Lu Zhang, Guan-Qun Zhou, Zhen-Yu Qi, Xiao-Jun He, Jia-Xiang Li, Ling-Long Tang, Yan-Ping Mao, Ai-Hua Lin, Jun Ma, Ying Sun |
Journal | BMC cancer
(BMC Cancer)
Vol. 17
Issue 1
Pg. 788
(Nov 23 2017)
ISSN: 1471-2407 [Electronic] England |
PMID | 29169335
(Publication Type: Journal Article)
|
Topics |
- Adult
- Carcinoma
(complications, diagnosis, epidemiology, radiotherapy)
- Female
- Humans
- Incidence
- Male
- Middle Aged
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
(complications, diagnosis, epidemiology, radiotherapy)
- Neck Muscles
(physiopathology)
- Neoplasm Staging
- ROC Curve
- Radiotherapy Dosage
- Radiotherapy, Intensity-Modulated
(adverse effects)
- Risk Factors
- Spasm
(diagnosis, epidemiology, etiology)
- Young Adult
|